Its definitely possible that with the opening up of more indications, theres going to be a higher demand and subsequent future shortages. With fallout from the tirzepatide shortage still ongoing and the compounded semaglutide deadlines fast approaching, it remains to be seen how, and indeed if, the FDA will enforce its legislation.
Clinics, laboratories, and healthcare facilities source it through approved distributors
Patients should be educated on the importance of monitoring and interpreting their blood sugar readings, especially before driving, operating machinery, or engaging in other activities where dizziness could pose a safety risk
If your vial sits at room temperature for several hours, some potency loss occurs
Definitely a space to watch closely as the market prepares for disruption
Vikram said